Evidence map›Paper›PMID 36620856›Full record

ArticleFrontiers in behavioral neuroscience2022

Alterations in prefrontal cortical neuregulin-1 levels in post-pubertal rats with neonatal ventral hippocampal lesions.

Kenya Watanabe, Osamu Nakagawasai, Syu-Ichi Kanno, Satoru Mitazaki, Hiroshi Onogi, Kohei Takahashi, Kei-Ichiro Watanabe, Koichi Tan-No, Masaaki Ishikawa, Lalit K Srivastava and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in behavioral neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Kenya WatanabeDivision of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Osamu NakagawasaiDivision of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Syu-Ichi KannoDivision of Clinical Pharmaceutical Therapy, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Satoru MitazakiDivision of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Hiroshi OnogiDivision of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Kohei TakahashiDivision of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Kei-Ichiro WatanabeCenter for Research on Counseling and Support Services, The University of Tokyo, Bunkyō-ku, Tokyo, Japan.
Koichi Tan-NoDivision of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Masaaki IshikawaDivision of Clinical Pharmaceutical Therapy, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Lalit K SrivastavaDouglas Hospital Research Centre, McGill University, Montreal, QC, Canada.
Remi QuirionDouglas Hospital Research Centre, McGill University, Montreal, QC, Canada.
Takeshi TadanoDivision of Pharmacology, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Tohoku Medical and Pharmaceutical University · JPFukushima Medical University Hospital · JPDouglas Mental Health University Institute · CAInternational University of Health and Welfare · JPKanazawa University · JPMcGill University · CATohoku Fukushi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic studies in humans have implicated the gene encoding neuregulin-1 (NRG-1) as a candidate susceptibility gene for schizophrenia. Furthermore, it has been suggested that NRG-1 is involved in regulating the expression and function of the

Indexed as

erbB4neonatal ventral hippocampal lesionneuregulin-1prefrontal cortexprepulse inhibitionschizophrenia

Identifiers

PMID36620856
PMCPMC9813588
OpenAlexW4312187006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.